Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology 01. January 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 94943  Previews Next
   
   Articles 1 - 20 / 1898853  
   
The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment.
Crit Rev Microbiol
Chan NSL, Cross C, Prestidge CA, Wardill HR, Bowen J, Joyce P.
PMID: 41477725 [PubMed - as supplied by publisher]


Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial.
EClinicalMedicine
Ge T, Zhang H, Zhu X, Teng M, Zhou Y, Wang S, Bian D, Zhang L, Hu H, Guo Q, Su J, Hu S, Yu H, Zhou Y, Huang J, Yang J, Zhu Y, Bao Y, Bao M, Hu X, He W, Zhang P.
PMID: 41477564 [PubMed]


Expression of DKK1, HOXC6, and YKT6 Genes in Subjects With Oral Squamous Cell Carcinoma Residing in Central India: A Case-Control Study.
Cureus
Haldar U, Gopal N, Prathipati K, Balkrishna AD, John JE.
PMID: 41477365 [PubMed]


Incorporating physicians' contouring style into auto-segmentation of clinical target volume for post-operative prostate cancer radiotherapy using a language encoder.
Mach Learn Health
Zhao H, Liao CY, Yang D, Jiang S, Nguyen D.
PMID: 41477361 [PubMed]


Recent advances in engineering nano/microrobots for tumor treatment.
Acta Pharm Sin B
Qin X, Xu R, Wu J, Liu Y, Wang T, Tu H, Li J, Pang Z.
PMID: 41477350 [PubMed]


m(6)A readers: Promising therapeutic targets in cancer treatment.
Acta Pharm Sin B
Wang X, Chen X, Wen S, Mou Y, Guo X, Jiang Z.
PMID: 41477346 [PubMed]


Ferroptosis meets cancer immunotherapy: Overcoming the crosstalk challenges through advanced drug delivery strategies.
Acta Pharm Sin B
Gan L, Lin X, Zhong Z, Zheng Y, Chen X, Chen J, Yue X, Liu Y, Pan X, Wu C, Huang Y, Wang W.
PMID: 41477324 [PubMed]


The impact of diet and gut microbiota on development, treatment, and prognosis in prostate cancer.
Front Nutr
Liu G, Yang F, Song W, Hou R.
PMID: 41477313 [PubMed]


Clinical application of boron neutron capture therapy for cancer treatment: A systematic review.
Precis Radiat Oncol
Zhou L, Chen Y, Peng M, Yin X, Liang H, Mo J, Zhang W, Liu Z.
PMID: 41477294 [PubMed]


SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies.
Drug Des Devel Ther
Su H, Li X, Wang S, Yang X, Jiang L, Luo H, Li Y, Zhou J, Huang Y, Li M.
PMID: 41477177 [PubMed - indexed for MEDLINE]


Identification and Validation of a Prognostic Signature Based on mRNAs Associated with Low-Density Lipoprotein Receptor-Related Proteins for Kidney Renal Clear Cell Carcinoma: Insights Into Tumor Immune Microenvironment, Mutation Patterns, and Personalized Treatment Strategies.
Int J Gen Med
Xie L, Zhou Y, Hu Z, Zhang S, Fan M, Huang X, Zhang W, Liu Z.
PMID: 41477155 [PubMed]


Response to Letter to the Editor: Optimizing Pulmonary Health and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial Combining Incentive Spirometry and Aerobic Exercise.
Arch Rehabil Res Clin Transl
Sari DM, Defi IR, Maharadja A, Trianasari N, Wijaya LCG, Santoso PHC, Candra GC.
PMID: 41477076 [PubMed]


Letter to the Editor: Optimizing Pulmonary Health and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial Combining Incentive Spirometry and Aerobic Exercise.
Arch Rehabil Res Clin Transl
Aphale P, Dokania S, Shekhar H.
PMID: 41477075 [PubMed]


G protein-coupled receptors as novel therapeutic targets in non-small-cell lung cancer.
Med Rev (2021)
Ma L, Zhang P, Sun JP.
PMID: 41477057 [PubMed]


Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients.
Front Immunol
Thielmann CM, Seier JA, Schielke L, Albrecht LJ, Zimmer L, Livingstone E, Zaremba A, Lodde G, Dissemond J, Sondermann W, Krefting F, Tasdogan A, Roesch A, Hadaschik E, Rambow F, Griewank K, Ugurel S, Schadendorf D, Placke JM.
PMID: 41476990 [PubMed - indexed for MEDLINE]


COVID-19-associated delayed-onset MuSK-positive myasthenia gravis presenting solely with respiratory failure: a case report.
Front Immunol
Cao XG, Ni JX, Zhu XF, Meng HD, Huang CJ.
PMID: 41476989 [PubMed - indexed for MEDLINE]


Above and beyond senescence and CAR T cell: advances and future perspectives.
Front Immunol
Rosas-Campos R, Arceo-Orozco S, Sandoval-Rodriguez A, Madrigal JA, Armendariz-Borunda J.
PMID: 41476987 [PubMed - indexed for MEDLINE]


Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL.
Front Immunol
Zhou Q, Jia R, Chen J, Tan Y, Ma Y, Luan M, Sheng X, Han X, Li S, Lu F, Ji C, Wang D, Ye J.
PMID: 41476984 [PubMed - indexed for MEDLINE]


Machine learning-derived cellular senescence index for predicting prognosis and drug sensitivity in patients with renal cell carcinoma.
Front Immunol
Meng L, Zhang H, Qiu Y, Zhu X, Ji X, Wang B, Zhang G, Xue Y, Wang C.
PMID: 41476960 [PubMed - indexed for MEDLINE]


Risk of Second Primary Cancer Among Patients with Thyroid Carcinoma in Finland: A Nationwide Population-Based Study.
Clin Epidemiol
Nikkilä R, Hirvonen E, Mäkitie A, Pitkäniemi J, Malila NK, Mäkitie RE.
PMID: 41476953 [PubMed]


   
   Articles 1 - 20 / 1898853    Page 1 of 94943  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1